Navigation Links
Drug Proves Effective in Slowing Melanomas
Date:4/15/2008

Riluzole, used to treat Lou Gehrig's disease, inhibits aggressive growth, study finds

TUESDAY, April 15 (HealthDay News) -- The drug riluzole, approved in the United States to treat amyotrophic lateral sclerosis (ALS), slows the growth of highly aggressive melanoma skin cancer, according to a new study.

A common feature of both melanoma and ALS (also called Lou Gehrig's disease) is an excess amount of the protein glutamate, a cellular growth factor or food for cells. Too much glutamate can overstimulate neurons to the point where they burn out -- a possible explanation for what happens in ALS, according to background information in the study. Overproduction of glutamate causes the growth and expansion of melanoma.

Riluzole (brand name Rilutek) inhibits the release of glutamate.

In laboratory tests using cultures of human melanoma cell lines, researchers at Rutgers University and the Cancer Institute of New Jersey found that riluzole appeared to switch off overproduction of glutamate and slow the growth rate of the melanoma cells. In tests on animals, the drug showed the same suppression of melanoma cell growth.

The researchers then started testing the drug on 11 people with late-stage (stage 3 or 4) melanoma. The patients in this phase 0 (exploratory, first-in-humans) trial received riluzole for two weeks.

"Our preliminary results show three solid positive responses in nine of the patients who had been able to complete the trial to date," Dr. James Goydos, a surgical oncologist at the Cancer Institute of New Jersey, said in a prepared statement.

Other patients in the group showed some indications of responding to the drug, and they'll be reassessed at the end of the trial.

The research was to be presented April 15 at the annual meeting of the American Association for Cancer Research, in San Diego.

The findings provide "enough data to show that we should go on to a
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. FDA Approves First Anti-Psychotic for Kids
2. Nasal Anthrax Vaccine Proves Effective in Animal Study
3. FDA Approves New Roche West Nile Virus Blood Screening Test
4. Study Demonstrates Marteks Algal DHA Oil Improves Blood Triglyceride Lipid Levels
5. Exercise and yoga improves quality of life in women with early-stage breast cancer
6. Toddler Study Proves Humans Outsmart Apes
7. Enhanced PrecyseCode 2X(TM) Further Accelerates Remote Coding and Improves Cash Flow for Hospitals
8. FDA Approves Osteoporosis Drug to Cut Breast Cancer Risk
9. FDA Approves LEVAQUIN(R) Short-Course Therapy for Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
10. FDA Approves SOMA(R) (carisoprodol) 250 mg
11. FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... VA (PRWEB) August 30, 2014 Seniors Guide, ... articles recently that focus on Alzheimer’s Disease, Dementia, and ... revealed to the public of being diagnosed with the Alzheimer’s, ... latest movie, “I’ll Be Me”. The movie, out on ... while focusing on his diagnosis of the disease – which ...
(Date:8/30/2014)... Insomnia causes disturbances in every aspect of life. ... insomnia and the steps often used to return back to ... the show at this link: Dr. Carol Francis Talk ... and will be podcasted at this link (Click Here) ... , "Insomnia causes countless unrecognized complications. Weight gain ...
(Date:8/30/2014)... HealthDay Reporter FRIDAY, Aug. 29, 2014 ... for broken bones or other orthopedic trauma shops around for ... Less-educated patients and patients who had used narcotic painkillers previously ... study lead author Dr. Brent Morris, a shoulder and neck ... that doctors aren,t talking to one another about the painkiller ...
(Date:8/30/2014)... 2014 Hastings and Hastings, a qualified ... throughout Arizona is pleased to report having saved a ... example among many cases where Hastings and Hastings has ... retain a greater portion of their settlement or recovery. ... a positive solution for Arizona car accident victims is ...
(Date:8/30/2014)... Administration of colchicine, a plant-based medication commonly used ... showed mixed results in reducing potential complications from ... the risk of gastrointestinal adverse effects, according to ... study is being released early online to coincide ... Cardiology Congress. , Common complications after cardiac surgery ...
Breaking Medicine News(10 mins):Health News:Alzheimer’s Disease and Dementia Focus on Retirement Website SeniorsGuideOnline.com 2Health News:Sleepless Nights, Exhausting Days, Mental Fog – Relief for Insomnia With Clinical Psychologist Dr. Carol Francis 2Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 2Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 3Health News:Hastings and Hastings Is Pleased To Report Having Saved A Client $67,100 On A Settlement Of $610,000 2Health News:Medication shows mixed results in reducing complications from cardiac surgery 2
... Wash., March 31 Cardiac Science,Corporation (Nasdaq: ... advanced cardiac diagnosis,resuscitation, rehabilitation, and informatics products, ... Cardiology conference that it completed,certification for its ... Systems. NextGen is a leading developer and ...
... 31 Ingenuity Systems, the,leading provider of ... that Path Designer, the new pathway publishing ... Best New Product by the scientific community ... San Francisco. Path,Designer enables researchers to create ...
... QLT Inc. (NASDAQ: QLTI;,TSX: QLT) announced today the ... phase II trial being conducted by QLT,s wholly-owned,subsidiary, ... preliminary,efficacy and safety of its latanoprost punctal plug ... hypertension. The punctal plug delivery,system is a non-invasive ...
... , , SUNDAY, March 30 (HealthDay News) -- Retired National ... problems, say researchers at the Mayo Clinic in Arizona. ... elite-level football players should begin in high school and ... , The Mayo team examined the cardiovascular health of ...
... findings that could come to define new standards ... conference of the American College of Cardiology, the ... world. These experts will gather beginning this weekend ... advances in cardiovascular medicine, science and education. , ...
... WASHINGTON, March 29 The second annual,National Walk ... National,Mall and raised $1.5 million to help build ... and to raise much-needed funds. The event,was sponsored ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080329/17897 ), The stars ...
Cached Medicine News:Health News:Cardiac Science Adds NextGen to Its Roster of Certified EMR System Partners 2Health News:Cardiac Science Adds NextGen to Its Roster of Certified EMR System Partners 3Health News:Cardiac Science Adds NextGen to Its Roster of Certified EMR System Partners 4Health News:Ingenuity's Path Designer is Selected as Best New Product by Life Science Community at 2008 Molecular Medicine Conference 2Health News:Ingenuity's Path Designer is Selected as Best New Product by Life Science Community at 2008 Molecular Medicine Conference 3Health News:QLT initiates phase II study of punctal plug drug delivery system for glaucoma & ocular hypertension 2Health News:QLT initiates phase II study of punctal plug drug delivery system for glaucoma & ocular hypertension 3Health News:QLT initiates phase II study of punctal plug drug delivery system for glaucoma & ocular hypertension 4Health News:Increased Heart Risk Seen for Retired NFL Players 2Health News:Experts from Penn's School of Medicine to present at ACC Annual Scientific Session 2Health News:Experts from Penn's School of Medicine to present at ACC Annual Scientific Session 3Health News:National Walk for Epilepsy Brings People and Celebrities Together for Epilepsy 2
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... Orthopedic Instrument Industry Report, 2014-2017" report to their ... and rising proportion of reimbursement for medical expenses, the ... with its scale presenting a CAGR of 19.2% during ... three product segments of orthopedic instruments in ...
(Date:8/29/2014)... , August 29, 2014 ... Seed Oil Market by Extraction type (SFE, Cold ... & Personal Care, Pharmaceutical, Food Supplements, Fragrance, & Others) ... by MarketsandMarkets, defines and segments the Amaranth Seed ... the market size in terms of value. The ...
(Date:8/29/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) ... District of New Jersey has ... Sandoz, Inc. regarding United Therapeutics, Remodulin ® product.  In ... U.S. Patent No. 6,765,117 is both valid and enforceable ... generic product until the expiration of that patent in ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4District Court Decision Received In Remodulin Patent Case 2
... bed is especially designed to make your bariatric ... caregivers who manage them. , ,When caring ... pulling up in bed, turning, sitting, standing ... for patients. Excel Care ES bed offers features ...
... Caregiver safety. Patient dignity. A single ... Bariatric Bed to provide added safety where ... is engineered to help protect the caregiver ... efficiency. The bed functions just like other ...
... We offer a wide selection of solutions ... therapy use. The sterile water for inhalation ... in plastic pour bottles in 500 and ... prefilled nebulizer kits or can be used ...
... Nebulizer Disposable Prefilled 28%-100% FIO 2 ... prefilled nebulizers provide unmatched performance and ease of ... aerosols adjustable from 28% to 100% FIO 2 ... sterile water for inhalation, USP; 0.45% sodium chloride ...
Medicine Products: